Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 27;515(7528):496-8.
doi: 10.1038/515496a.

Cancer: Antitumour immunity gets a boost

Jedd D Wolchok  1 , Timothy A Chan  2
Affiliations

Cancer: Antitumour immunity gets a boost

Jedd D Wolchok et al. Nature. .
No abstract available

PubMed Disclaimer

Figures

Figure 1 |
Figure 1 |. Checkpoint blockade activates antitumour immunity.
a, Tumour cells express both cancer-driving mutations and ‘passenger’ mutations that cause the expression of neoantigens — ‘new’ molecular structures that, when presented by MHC proteins on the cell surface, are recognized by T cells of the immune system as being foreign, leading to an immune response against the tumour. However, interactions between the receptor PD-1 and its ligand PD-L1, which are expressed on tumour cells, T cells and other immune cells such as macrophages, activate signalling pathways that inhibit T-cell activity and thus inhibit the antitumour immune response. b, Antibodies that block the PD-1 pathway by binding to PD-1 or PD-L1 can reactivate T-cell activity and proliferation, leading to enhanced antitumour immunity.
See this image and copyright information in PMC

References

    1. Coley WB Proc. R. Soc. Med. 3, 1–48 (1910). - PMC - PubMed
    1. Dunn GP, Bruce AT, Ikeda H, Old LJ & Schreiber RD Nature Immunol. 3, 991–998 (2002). - PubMed
    1. Koebel CM et al. Nature 450, 903–907 (2007). - PubMed
    1. Shankaran V et al. Nature 410, 1107–1111 (2001). - PubMed
    1. Powles T et al. Nature 515, 558–562 (2014). - PubMed

MeSH terms

Substances